Integrated genomic surveillance enables tracing of person-to-person SARS-CoV-2 transmission chains during community transmission and reveals extensive onward transmission of travel-imported infections, Germany, June to July 2021

Torsten Houwaart(Düsseldorf University Hospital), Samir Belhaj(Gesundheitsamt), Emran Tawalbeh(Gesundheitsamt), Dirk Nagels(Gesundheitsamt), Yara Fröhlich(Düsseldorf University Hospital), Patrick Finzer(Düsseldorf University Hospital), Pilar Ciruela(Instituto de Salud Carlos III), Aurora Sabrià, Mercè Herrero, Cristina Andrés(Vall d'Hebron Hospital Universitari), Andrés Antón(Vall d'Hebron Hospital Universitari), Assia Benmoumene(Düsseldorf University Hospital), Dounia Asskali(Düsseldorf University Hospital), Hussein Haidar(Düsseldorf University Hospital), Janina von Dahlen(Düsseldorf University Hospital), Jessica Nicolai(Düsseldorf University Hospital), Mygg Stiller, Jacqueline Blum, Christian E. Lange, Carla Adelmann(Gesundheitsamt), Britta Schroer(Gesundheitsamt), Ute Osmers(Klinikum Leverkusen), Christiane Grice(Klinikum Leverkusen), Phillipp Kirfel(Klinikum Leverkusen), Hassan Jomaa(Klinikum Leverkusen), Daniel Strelow(Düsseldorf University Hospital), Lisanna Hülse(Düsseldorf University Hospital), Moritz Pigulla(Gesundheitsamt), Pascal Kreuzer(Gesundheitsamt), Alona Tyshaieva(Düsseldorf University Hospital), Jonas Weber(Düsseldorf University Hospital), Tobias Wienemann(Düsseldorf University Hospital), Malte Kohns Vasconcelos(Düsseldorf University Hospital), Katrin Hoffmann, Nadine Lübke(Düsseldorf University Hospital), Sandra Hauka(Düsseldorf University Hospital), Marcel Andrée(Düsseldorf University Hospital), Claus Jürgen Scholz(Laboratory Dr. Wisplinghoff), Nathalie Jazmati(Laboratory Dr. Wisplinghoff), Klaus Göbels(Gesundheitsamt), Rainer B. Zotz(Düsseldorf University Hospital), Klaus Pfeffer(Düsseldorf University Hospital), Jörg Timm(Düsseldorf University Hospital), Lutz Ehlkes(Gesundheitsamt), Andreas Walker(Düsseldorf University Hospital), Alexander Dilthey(Düsseldorf University Hospital), German COVID-19 OMICS Initiative (DeCOI)(German Doctors)
Eurosurveillance
October 27, 2022
Cited by 14Open Access
Full Text

Abstract

BackgroundTracking person-to-person SARS-CoV-2 transmission in the population is important to understand the epidemiology of community transmission and may contribute to the containment of SARS-CoV-2. Neither contact tracing nor genomic surveillance alone, however, are typically sufficient to achieve this objective.AimWe demonstrate the successful application of the integrated genomic surveillance (IGS) system of the German city of Düsseldorf for tracing SARS-CoV-2 transmission chains in the population as well as detecting and investigating travel-associated SARS-CoV-2 infection clusters.MethodsGenomic surveillance, phylogenetic analysis, and structured case interviews were integrated to elucidate two genetically defined clusters of SARS-CoV-2 isolates detected by IGS in Düsseldorf in July 2021.ResultsCluster 1 (n = 67 Düsseldorf cases) and Cluster 2 (n = 36) were detected in a surveillance dataset of 518 high-quality SARS-CoV-2 genomes from Düsseldorf (53% of total cases, sampled mid-June to July 2021). Cluster 1 could be traced back to a complex pattern of transmission in nightlife venues following a putative importation by a SARS-CoV-2-infected return traveller (IP) in late June; 28 SARS-CoV-2 cases could be epidemiologically directly linked to IP. Supported by viral genome data from Spain, Cluster 2 was shown to represent multiple independent introduction events of a viral strain circulating in Catalonia and other European countries, followed by diffuse community transmission in Düsseldorf.ConclusionIGS enabled high-resolution tracing of SARS-CoV-2 transmission in an internationally connected city during community transmission and provided infection chain-level evidence of the downstream propagation of travel-imported SARS-CoV-2 cases.


Related Papers

No related papers found

Powered by citation graph analysis